⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RGNX News
REGENXBIO Inc.
RGNX'S "TRANSFORMATIONAL" PROMISE BECAME A $2.40 LOSS FOR INVESTORS: SUEWALLST
prnewswire.com
RGNX
Bronstein, Gewirtz & Grossman LLC Urges REGENXBIO Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
RGNX
Portnoy Law Firm Announces Class Action on Behalf of REGENXBIO, Inc. Investors
globenewswire.com
RGNX
Form 8-K
sec.gov
RGNX
REGENXBIO Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
prnewswire.com
RGNX
RGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that REGENXBIO Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
RGNX
Pomerantz LLP Highlights Class Action Filing Against REGENXBIO Inc. – RGNX
accessnewswire.com
RGNX
UPCOMING DEADLINE: REGENXBIO (RGNX) Securities Fraud Class Action – April 14, 2026 Lead Plaintiff Deadline
globenewswire.com
RGNX
REGENXBIO Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RGNX
prnewswire.com
RGNX
REGENXBIO Announces Presentations at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
prnewswire.com
RGNX